That is the fastest that could be achieved without big money or big pharma help and still remain independently controlled by existing shareholders. Where others would have fallen short, Linda found a way in spite of the added pressure of deliberate and illegal manipulation of share price which created even more dilution. Those desiring a cheap buyout or fine for their part in price suppression and development delays will find out the hard way that most shares are being held onto very tightly until the full intrinsic value is unlocked. Best wishes.
Market Data 
Markets 
AI
